Published in Medical Imaging Week, January 20th, 2007
This trend article about Pfizer, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Identification of enzymes responsible for primary and sequential oxygenation reactions of capravirine in human liver microsomes," is now available. "Capravirine, a new non-nucleoside reverse transcriptase inhibitor, undergoes extensive oxygenation reactions, including N-oxidation, sulfoxidation, sulfonation, and hydroxylation in humans. Numerous primary (mono-oxygenated) and sequential (di-, tri-, and tetraoxygenated) metabolites of capravirine are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week